156 related articles for article (PubMed ID: 33483237)
1. Perioperative blood transfusion is not an independent predictor for worse outcomes in retroperitoneal sarcoma surgery.
Wong B; Apte SS; Tirotta F; Parente A; Mathieu J; Ford SJ; Desai A; Almond M; Nessim C
Eur J Surg Oncol; 2021 Jul; 47(7):1763-1770. PubMed ID: 33483237
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.
MacNeill AJ; Gronchi A; Miceli R; Bonvalot S; Swallow CJ; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Barretta F; Raut CP; Strauss DC
Ann Surg; 2018 May; 267(5):959-964. PubMed ID: 28394870
[TBL] [Abstract][Full Text] [Related]
3. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
4. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG).
Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Rutkowski P; Blay JY; Strauss D; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Swallow CJ; Bagaria SP; Canter RJ; Mullen JT; Schrage Y; Pennacchioli E; van Houdt W; Cardona K; Fiore M; Gronchi A; Lahat G
Ann Surg Oncol; 2021 May; 28(5):2705-2714. PubMed ID: 33389288
[TBL] [Abstract][Full Text] [Related]
6. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.
Wilkinson KH; Ethun CG; Hembrook M; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Weber S; Gamblin TC; Cardona K; Clarke CN
J Surg Res; 2019 Jan; 233():154-162. PubMed ID: 30502242
[TBL] [Abstract][Full Text] [Related]
8. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
[TBL] [Abstract][Full Text] [Related]
9. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
[TBL] [Abstract][Full Text] [Related]
10. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
[TBL] [Abstract][Full Text] [Related]
11. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
Baumeister P; Canis M; Reiter M
PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001
[TBL] [Abstract][Full Text] [Related]
12. Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.
Lane WO; Cramer CK; Nussbaum DP; Speicher PJ; Gulack BC; Czito BG; Kirsch DG; Tyler DS; Blazer DG
J Surg Oncol; 2015 Sep; 112(4):352-8. PubMed ID: 26238282
[TBL] [Abstract][Full Text] [Related]
13. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
14. Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity.
Bartlett EK; Roses RE; Meise C; Fraker DL; Kelz RR; Karakousis GC
J Surg Oncol; 2014 May; 109(6):606-11. PubMed ID: 24374652
[TBL] [Abstract][Full Text] [Related]
15. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
[TBL] [Abstract][Full Text] [Related]
16. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
17. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
[TBL] [Abstract][Full Text] [Related]
18. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
19. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; Rouprêt M; Fisch M; Scherr DS; Shariat SF
BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
[TBL] [Abstract][Full Text] [Related]
20. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
